Brief: Imunon Inc Preclinical Data Showing Strong Immunogenicity And Protection With Co's Placcine DNA-Based Vaccines Modality

Imunon

07/08/2023 16:25

Aug 7 (Reuters) - Imunon Inc  IMNN.O :
    * IMUNON INC: PRECLINICAL DATA SHOWING STRONG IMMUNOGENICITY
AND
PROTECTION WITH CO'S PLACCINE DNA-BASED VACCINES MODALITY
    * IMUNON INC: STUDY USED CO'S PROPRIETARY FORMULATION
AGAINST
SPIKE PROTEINS FROM TWO SARS-COV-2 VARIANTS, BOTH ALONE AND IN
COMBINATION
    * IMUNON INC: STUDY SHOW IMUNON'S PROPRIETARY FORMULATION OF
FUNCTIONALIZED POLYMER PROTECTED DNA FROM DEGRADATION
    * IMUNON INC: STUDY SHOW IMUNON'S COMBINATION WITH AN
ADJUVANT LED
TO AN INCREASE IN PROTEIN EXPRESSION
    * IMUNON INC: LOOKING FORWARD TO COMMENCING A HUMAN CLINICAL
TRIAL
WITH PLACCINE IN SARS-COV-2 DURING Q1 OF 2024

Source text for Eikon:  ID:nGNX3BrbMm 
Further company coverage:  IMNN.O